La vendita allo scoperto per Intuitive Surgical dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Intuitive Surgical. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Intuitive Surgical (NASDAQ:ISRG) Azioni, Report sulle vendite allo scoperto

Intuitive Surgical

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.

Intuitive Surgical Inc

Erste Group analyst Hans Engel upgrades Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) from Hold to Buy.

News

Upgrades

Analyst Ratings

ISRG

Erste Group Upgrades Intuitive Surgical to Buy

Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) is a &#8220;fantastic company with an expensive stock,&#8221; <a href="https://www.benzinga.com/topic/jim-cramer">according to CNBC's Jim Cramer</a>.
On Oct. 17, Intuitive Surgical reported third-quarter revenue of $2.04 billion, beating the consensus estimate of $2 billion.
During the latest edition of &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Cramer said Energy Transfer LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) <a href="https://www.benzinga.com/quote/ET/earnings">is a buy</a>.
Energy Transfer reported quarterly earnings of 32 cents per share which missed the analyst consensus estimate of 37 cents per share. The company reported quarterly sales of $20.772 billion which missed the analyst consensus estimate of $22.297 billion.
&#8220;Let it ride,&#8221; Cramer said when asked about T-Mobile US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>).
On Oct. 23, T-Mobile reported quarterly earnings of $2.61 per share, which beat the analyst consensus estimate of $2.41 per share.
Cramer recommended buying Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>). &#8220;I think it still works higher,&#8221; he added.
On Nov. 4, Constellation Energy reported third-quarter results and revised its FY24 adjusted EPS guidance, which is below estimates.
When asked about International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>), he said, &#8220;I think we can hold it.&#8221;
On Oct. 23, IBM reported third-quarter revenue of $14.968 billion, missing the consensus estimate of $15.07 billion, according to Benzinga Pro.
The Mad Money host said he is not recommending Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>). &#8220;I think they have a lot of companies that are up against them,&#8221; he noted.
On Nov. 11, Keybanc analyst Eric Heath maintained Snowflake with an Overweight and lowered the price target from $168 to $150.
Price Action:
<ul>
<li>Energy Transfer shares fell 1.1% to settle at $17.05 on Tuesday.</li>
<li>Intuitive Surgical shares gained 0.3% to close at $537.07.</li>
<li>T-Mobile shares rose 0.3% to close at $239.00 on Tuesday.</li>
<li>Constellation Energy shares fell 3.6% to settle at $228.70 during the session.</li>
<li>IBM shares fell 0.5% to close at $210.86 on Tuesday.</li>
<li>Snowflake shares gained 1.6% to settle at $125.46.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/41899303/top-3-tech-and-telecom-stocks-which-could-rescue-your-portfolio-in-q4">Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio In Q4</a></li>
</ul>
Courtesy of Intuitive Surgical

Long Ideas

Markets

Media

Trading Ideas

SNOW

TMUS

Jim Cramer Says Intuitive Surgical Is A 'Fantastic, Expensive Company'

Intuitive Surgical's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NYSE">ISRG</a>) short percent of float has risen 9.0% since its last report. The company recently reported that it has 3.85 million shares sold short, which is 1.09% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.74 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Intuitive Surgical Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731430819_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Intuitive Surgical has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Intuitive Surgical's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Intuitive Surgical's peer group average for short interest as a percentage of float is 4.16%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Intuitive Surgical?

Each week,&nbsp;Benzinga&#8217;s Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Read Also:&nbsp;<a href="https://www.benzinga.com/top-stories/24/11/41718416/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-october-2024-where-do-tesla-nvidia-apple-d" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?</a>
Here's a look at the Benzinga Stock Whisper Index for the week of Nov. 8:
Insmed Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>): The biopharmaceutical company saw increased interest from investors over the week, which comes after the company <a href="https://investor.insmed.com/2024-10-31-Insmed-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Business-Update">reported </a>third-quarter financial results and provided a company update in late October. The company said ARIKAYCE had revenue of $93.4 million in the quarter, up 18% year-over-year. 
Insmed also said its NDA submission for Brensocatib in Bronchiectasis is on track for the fourth quarter and is expected to launch in the U.S. in mid-2025. 
H.C. Wainwright reiterated a Buy rating and $90 price target on the stock <a href="https://www.benzinga.com/quote/INSM/analyst-ratings">after the quarterly results</a>. Truist reiterated a Buy rating and raised the price target from $100 to $105. Investor interest could increase in the coming weeks with the company scheduled to participate in several conferences including ones from Guggenheim (Nov. 11), UBS Global (Nov. 12), Wolfe Research (Nov. 20) and Jefferies (Nov. 21).
Insmed shares were up over 8% in the last five trading days, as seen on the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1">Benzinga Pro chart</a> below, and are up over 140% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="506" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135456/Screenshot-234.png" alt="" class="wp-image-638350" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135456/Screenshot-234.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135456/Screenshot-234-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135456/Screenshot-234-768x389.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Applied Industrial Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>): The industrial company was one of several in the sector to see strong interest from readers, which could be related to Donald Trump winning<a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election"> the 2024 election.</a> Industrials were a top performing sector under <a href="https://www.benzinga.com/general/politics/24/11/41783357/how-did-s-p-500-sectors-perform-during-trumps-first-term-could-this-time-be-different">Trump&#8217;s previous four years</a> in the White House. 
The company also recently <a href="https://ir.applied.com/news/news-details/2024/Applied-Industrial-Technologies-Reports-Fiscal-2025-First-Quarter-Results/default.aspx">reported </a>first-quarter financial results with earnings per share of $2.36 and revenue of $1.10 billion, beating Street consensus estimates of $2.27 and $1.09 billion respectively. Applied Industrial also increased its fiscal 2025 earnings per share guidance to a range of $9.25 to $10.00, up from prior guidance of $9.20 to $9.95 and ahead of a Street estimate of $9.39. 
Analysts <a href="https://www.benzinga.com/quote/AIT/analyst-ratings">raised their price targets</a> on the stock after the quarterly results. The stock was up over 15% in the last five trading days and is up over 50% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="503" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135510/Screenshot-236.png" alt="" class="wp-image-638351" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135510/Screenshot-236.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135510/Screenshot-236-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135510/Screenshot-236-768x388.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>): The specialty grocery retailer saw strong interest from Benzinga readers during the week, which comes after <a href="https://investors.sprouts.com/news/news-details/2024/Sprouts-Farmers-Market-Inc.-Reports-Third-Quarter-2024-Results/default.aspx">recent </a>quarterly results and with shares trading at 52-week highs. The company's third-quarter earnings per share of 91 cents and revenue of $1.90 billion beat Street estimates of 76 cents per share and $1.88 billion respectively.
The company said the third quarter was exceptional and CEO Jack Sinclair highlighted "robust traffic growth." Same store sales were up 8.4% in the third quarter. The company opened nine new stores, ending the quarter with 428 stores in 23 states. 
Goldman Sachs recently <a href="https://www.benzinga.com/quote/SFM/analyst-ratings">maintained a Buy rating </a>on the stock and raised the price target from $127 to $159. Wells Fargo maintained an Equal-Weight rating on the stock and raised the price target from $90 to $130. 
The stock was up over 10% over the last five trading days, and shares are up over 190% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="503" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135528/Screenshot-237.png" alt="" class="wp-image-638353" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135528/Screenshot-237.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135528/Screenshot-237-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135528/Screenshot-237-768x388.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>): The medical devices company saw strong interest from readers over the last week, with shares trading at 52-week highs Friday. 
The company recently reported <a href="https://www.benzinga.com/news/earnings/24/10/41391471/intuitive-surgical-stock-pops-on-q3-earnings-beat-da-vinci-procedures-climb-18-regulatory-clearance">third-quarter financial results </a>with revenue of $2.04 billion beating a Street consensus estimate of $2.0 billion and earnings per share of $1.84 beating a Street consensus estimate of $1.63. Intuitive Surgical reported revenue growth of 17% year-over-year in the quarter, with worldwide da Vinci procedures up 18% year-over-year. 
The company also placed 379 da Vinci systems in the quarter, up from 312 in the prior quarter. There are 9,539 installed da Vinci surgical systems as of the end of the quarter. Intuitive obtained regulatory clearance for the da Vinci 5 surgical system in South Korea in October. 
The earnings report saw several<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406234/intuitive-surgical-posts-q3-earnings-beat-these-analysts-raise-forecasts-on-dv5-upt"> analysts raise their price targets </a>on the stock. Analysts see the company's updated da Vinci 5 system, which can be used for more types of surgeries as a growth catalyst moving forward. Shares of Intuitive Surgical were up around six percent in the last five days and are up over 60% year-to-date.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135542/Screenshot-238.png" alt="" class="wp-image-638354" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135542/Screenshot-238.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135542/Screenshot-238-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135542/Screenshot-238-768x387.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Mueller Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLI#NYSE">MLI</a>): The industrials company was another in the sector that saw increased interest and a soaring stock price, potential from Trump's 2024 election win. The company recently <a href="https://ir.muellerindustries.com/news/press-releases/detail/178/mueller-industries-inc-reports-third-quarter-2024-earnings">reported </a>third-quarter net sales of $997.8 million, beating a Street consensus estimate of $936.0 million and quarterly earnings per share of $1.48, which beat a Street estimate of $1.32. Mueller Industries said the revenue growth came from recently acquired businesses and higher copper prices in the quarter.
"We anticipated that declining interest rates and moderating inflation, combined with the resolution of election related uncertainty, will create a more stable and favorable environment for us," Mueller CEO Greg Christopher said.
The stock was up 13% over the last five days and is up over 100% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="508" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135559/Screenshot-240.png" alt="" class="wp-image-638355" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135559/Screenshot-240.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135559/Screenshot-240-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135559/Screenshot-240-768x392.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Stay tuned for next week&#8217;s report, and follow Benzinga Pro for all the latest headlines and&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul>
<li><a href="https://www.benzinga.com/exclusives/24/10/41405659/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">October 18</a></li>
<li><a href="https://www.benzinga.com/real-estate/reit/24/10/41549488/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">October 25</a></li>
<li><a href="https://www.benzinga.com/exclusives/24/11/41693907/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">November 1</a></li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/24/11/41779731/trump-victory-sends-bank-stocks-higher-leading-s-p-500-on-regulatory-hopes">Trump Victory Sends Bank Stocks Higher, Leading S&amp;P 500 On Regulatory Hopes</a></li>
</ul>
Photo: Benzinga

Exclusives

INSM

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

On CNBC's &#8220;Mad Money Lightning Round,&#8221; <a href="https://www.benzinga.com/topic/jim-cramer">Jim Cramer recommended</a> buying Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
On Oct. 17, Intuitive Surgical reported third-quarter revenue of $2.04 billion, beating the consensus estimate of $2 billion. The robotic-assisted surgery company reported third-quarter adjusted earnings of $1.84 per share, beating analyst estimates of $1.63 per share, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Kimco Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIM#NYSE">KIM</a>) is a &#8220;great operator, just own it right through,&#8221; he said.
On Oct. 1, Kimco Realty announced the acquisition of Waterford Lakes Town Center, a 976,000-square-foot signature asset spanning 79 acres in Orlando, Florida, for $322 million, including the assumption of a $164 million mortgage.
&#8220;That is such a hard story to understand,&#8221; Cramer said when asked about Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>).
On Oct. 28, Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $71 to $72.
The &#8220;Mad Money&#8221; host said CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) is a buy.
On Oct. 22, CrowdStrike partnered with Fortinet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) to enhance endpoint and firewall protection by integrating its AI-native security from the Falcon platform with FortiGate next-generation firewalls (NGFW).
Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) is a &#8220;high speculative&#8221; stock, he said.
On Oct. 24, Keybanc analyst Michael Leshock maintained Rocket Lab with an Overweight and raised the price target from $11 to $12.
Price Action:
<ul>
<li>Intuitive Surgical shares gained 1.1% to settle at $516.31 on Tuesday.</li>
<li>Kimco shares declined 0.9% to close at $23.67 on Tuesday.</li>
<li>Nutanix shares rose 1.3% to settle at $64.97 during the session.</li>
<li>CrowdStrike shares gained 3.2% to settle at $310.94 on Tuesday.</li>
<li>Rocket Lab gained 1.9% to settle at $11.47 on Tuesday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41599928/top-3-tech-and-telecom-stocks-which-could-rescue-your-portfolio-for-october">Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio For October</a></li>
</ul>
Photo: s_bukley/Shutterstock.com

CRWD

FTNT

NTNX

RKLB

Jim Cramer Says Buy CrowdStrike Stock, Calls This Aerospace Manufacturer A 'High Speculative' Stock

AI-themed exchange-traded funds (ETFs) are witnessing a significant surge as asset managers capitalize on the growing enthusiasm surrounding <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence</a>. This year, over one-third of the two dozen AI-focused ETFs were launched, according to Morningstar.
What Happened: In the past week alone, three new ETFs have entered the AI sector, including one that was rebranded to specifically focus on artificial intelligence, Reuters reported on Monday. The total assets of AI ETFs have now reached $4.5 billion, approaching the $5.5 billion held by nuclear power-themed ETFs and surpassing the $1.37 billion in the cannabis sector.
Daniel Sotiroff, a senior analyst at Morningstar, remarked on the trend, stating, &#8220;I&#8217;m not surprised their ranks are multiplying.&#8221; 
He emphasized that the industry&#8217;s rapid pace attracts investors eager for quick returns, according to the report.
See Also: <a href="https://www.benzinga.com/markets/equities/24/10/41560703/november-interest-rate-cut-almost-a-done-deal-as-blackout-begins-10-stocks-surging-the-most-sinc?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">November Interest Rate Cut Almost A Done Deal As Blackout Begins: 10 Stocks Surging The Most Since Fed&#8217;s Last Decision</a>
As per Benzinga Pro data, here are how some of the AI-based ETFs performed over the past year:
Global X Robotics and Artificial Intelligence ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOTZ#NASDAQ">BOTZ</a>): BOTZ, currently with net assets worth $2.51 billion and NAV of $31.59, climbed 40.39%. Its top AI-related holdings include Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and biotech firm Intuitive Surgical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
Global X Artificial Intelligence &amp; Technology ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIQ#NASDAQ">AIQ</a>): AIQ, which has $2.27 billion in net assets and $37.36 NAV, increased by 43.64%. Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), Cisco Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), and Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) are some of its top AI-related holdings.
iShares US Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYW#NYSE">IYW</a>): IYW gained 50.72% in the past year. The ETF has an NAV of $155.42 and $19.24 billion in net assets. It also gives exposure to tech stocks like Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Nvidia, Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) which have witnessed stellar growth, thanks to AI buzz.
Fidelity MSCI Information Technology Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTEC#NYSE">FTEC</a>): The ETF witnessed a 48.55% growth while exposing to stocks like Apple, Microsoft, Nvidia, Alphabet and Broadcom. It holds $12.05 billion in net assets. 
Why It Matters: The surge in AI-themed ETFs is part of a broader trend driven by the increasing demand for artificial intelligence technologies. Recently, Nvidia briefly surpassed Apple to become the <a href="https://www.benzinga.com/markets/equities/24/10/41551461/nvidia-overtakes-apple-as-worlds-most-valuable-company-again">world&#8217;s most valuable company</a>, fueled by the demand for its AI supercomputing chips. This highlights the growing importance of AI in the tech sector.
Moreover, the <a href="https://www.benzinga.com/news/24/10/41351070/imf-warns-ai-in-stock-trading-can-boost-efficiency-but-warns-of-increased-market-volatility">International Monetary Fund</a> (IMF) has noted AI&#8217;s potential to enhance market efficiency but warns of increased volatility and cyber threats. The IMF&#8217;s Global Financial Stability Report suggests that AI-driven trading could revolutionize markets, although its adoption remains limited. The report also cautions about the potential shift of investments to less regulated nonbank financial intermediaries, complicating market oversight.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41517027/five-us-banks-face-billions-in-losses-as-silvers-price-spike-hits-short-sellers-hard-report?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Five US Banks Face Billions In Losses As Silver&#8217;s Price Spike Hits Short Sellers Hard: Report</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Unsplash

Sector ETFs

ETFs

General

AAPL

AVGO

BOTZ

CSCO

FTEC

iShares Dow Jones US Technology Sector Index Fund

MSFT

NVDA

ORCL

More Than A Third Of AI-Based ETFs Were Launched In 2024, Focusing On Nvidia, Microsoft, Apple And Meta, Among Others: Here's How Some Of Them Have Performed This Year So Far

Financial giants have made a conspicuous bearish move on Intuitive Surgical. Our analysis of options history for Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) revealed 8 unusual trades.
Delving into the details, we found 12% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $426,801, and 6 were calls, valued at $285,918.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $350.0 to $520.0 for Intuitive Surgical over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Intuitive Surgical options trades today is 147.75 with a total volume of 588.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Intuitive Surgical's big money trades within a strike price range of $350.0 to $520.0 over the last 30 days.
<h3>Intuitive Surgical 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729888259_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.3</td>
<td>$7.9</td>
<td>$7.9</td>
<td>$465.00</td>
<td>$253.5K</td>
<td style="text-align: right;">94</td>
<td style="text-align: right;">322</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$47.1</td>
<td>$46.7</td>
<td>$46.9</td>
<td>$500.00</td>
<td>$173.2K</td>
<td style="text-align: right;">57</td>
<td style="text-align: right;">42</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$168.7</td>
<td>$167.6</td>
<td>$168.6</td>
<td>$350.00</td>
<td>$67.4K</td>
<td style="text-align: right;">348</td>
<td style="text-align: right;">8</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$37.3</td>
<td>$36.7</td>
<td>$37.0</td>
<td>$520.00</td>
<td>$55.5K</td>
<td style="text-align: right;">92</td>
<td style="text-align: right;">15</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$170.5</td>
<td>$168.6</td>
<td>$168.6</td>
<td>$350.00</td>
<td>$50.5K</td>
<td style="text-align: right;">348</td>
<td style="text-align: right;">3</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
<h3>Present Market Standing of Intuitive Surgical</h3>
<ul>
<li>With a volume of 979,283, the price of ISRG is down -0.07% at $511.27. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 88 days.</li>
</ul>
<h3>What The Experts Say On Intuitive Surgical</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $543.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from RBC Capital persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $525. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $570. 
&#x2A; Consistent in their evaluation, an analyst from Baird keeps a Outperform rating on Intuitive Surgical with a target price of $565. 
&#x2A; An analyst from Raymond James persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $540. 
&#x2A; An analyst from BTIG has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $518. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuitive Surgical with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Market Whales and Their Recent Bets on ISRG Options

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 20 years by 20.19% on an annualized basis producing an average annual return of 28.68%. Currently, Intuitive Surgical has a market capitalization of $182.11 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 20 years ago, it would be worth $15,521.76 today based on a price of $511.30 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729778412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today

In the current market session, Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) stock price is at $515.80, after a 0.59% decrease. However, over the past month, the company's stock spiked by 6.48%, and in the past year, by 93.47%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1729615537_0.png" alt="Past Year Chart" />

<h3>Intuitive Surgical P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Intuitive Surgical has a lower P/E than the aggregate P/E of 263.65 of the Health Care Equipment &amp; Supplies industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1729615537_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Price Over Earnings Overview: Intuitive Surgical

Whales with a lot of money to spend have taken a noticeably bearish stance on Intuitive Surgical.
Looking at options history for Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) we detected 21 trades.
If we consider the specifics of each trade, it is accurate to state that 28% of the investors opened trades with bullish expectations and 66% with bearish.
From the overall spotted trades, 11 are puts, for a total amount of $884,979 and 10, calls, for a total amount of $2,075,713.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $250.0 to $620.0 for Intuitive Surgical over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Intuitive Surgical's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuitive Surgical's whale activity within a strike price range from $250.0 to $620.0 in the last 30 days. 
<h3>Intuitive Surgical Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729531821_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$63.9</td>
<td>$63.2</td>
<td>$63.2</td>
<td>$470.00</td>
<td>$1.2M</td>
<td style="text-align: right;">313</td>
<td style="text-align: right;">270</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$64.0</td>
<td>$63.2</td>
<td>$63.2</td>
<td>$470.00</td>
<td>$316.0K</td>
<td style="text-align: right;">313</td>
<td style="text-align: right;">70</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$97.1</td>
<td>$94.0</td>
<td>$97.1</td>
<td>$570.00</td>
<td>$184.4K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">21</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$101.9</td>
<td>$97.4</td>
<td>$101.9</td>
<td>$580.00</td>
<td>$142.6K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">21</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$44.4</td>
<td>$44.3</td>
<td>$44.32</td>
<td>$500.00</td>
<td>$132.9K</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">54</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
After a thorough review of the options trading surrounding Intuitive Surgical, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Intuitive Surgical</h3>
<ul>
<li>With a volume of 682,367, the price of ISRG is down -0.47% at $518.69. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 92 days.</li>
</ul>
<h3>What Analysts Are Saying About Intuitive Surgical</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $540.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Intuitive Surgical, maintaining a target price of $549. 
&#x2A; An analyst from BTIG has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $535. 
&#x2A; An analyst from Piper Sandler downgraded its action to Overweight with a price target of $538. 
&#x2A; An analyst from RBC Capital persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $555. 
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $525. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuitive Surgical with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Smart Money Is Betting Big In ISRG Options

This week, the Vanguard S&amp;P 500 ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NASDAQ">VOO</a>) saw a roughly 0.7% gain, reflecting a broadly positive sentiment on Wall Street driven by a combination of upbeat earnings and <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41386234/strong-september-retail-sales-put-feds-next-move-in-doubt-interest-rate-cuts-are-">macroeconomic factors</a>. 
VOO, which is designed to track the performance of the S&amp;P 500, benefits from movements in its underlying components, making it a key barometer for the overall U.S. stock market.
What&#8217;s Happening: One of the major drivers for VOO's upward movement was a strong start to earnings season that boosted investor confidence. Notably, Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) surged 10% <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406623/netflix-should-continue-to-outperform-6-analysts-on-streaming-stocks-q3-earnings">after reporting an earnings beat</a>.
As Netflix is a significant part of the S&amp;P 500, its performance positively influenced VOO's price. Other companies, such as Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), which jumped over 9% on earnings, further contributed to the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406234/intuitive-surgical-posts-q3-earnings-beat-these-analysts-raise-forecasts-on-dv5-upt">bullish market sentiment</a>.
On Thursday, semiconductor stocks fueled a major push for the S&amp;P 500, as <a href="https://www.benzinga.com/news/earnings/24/10/41373163/nvidia-supplier-tsmc-reports-q3-revenue-earnings-beat-amid-rising-demand-for-ai-chips">strong earnings</a> from Taiwan Semiconductor Mfg. Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSMC#NYSE">TSMC</a>) invigorated investor confidence in the tech sector.
Read Also: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/10/41407647/spy-reaches-600-billion-in-assets-oldest-us-etf-hits-milestone-as-all-time-highs-conti">SPY Reaches $600 Billion In Assets: Oldest US ETF Hits Milestone As All-Time Highs Continue</a>
This semiconductor rally played a pivotal role in driving the S&amp;P 500 higher, and by extension, VOO, as technology remains one of the largest sectors in the index.
What Else: Gold miners saw strong momentum as gold prices reached new record highs, with the VanEck Gold Miners ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NASDAQ">GDX</a>) climbing nearly 4% Friday.
While VOO's exposure to gold miners is limited, the broader gains in commodity-related sectors helped balance weaker performances in sectors like energy.
Macroeconomic data released on Thursday also played a role in sustaining the market's positive momentum. September retail sales exceeded expectations, signaling robust consumer spending, while jobless claims fell, underscoring labor market strength. 
Although the positive data slightly diminished hopes for Federal Reserve rate cuts in November, it reinforced the view of economic resilience, which supported investor sentiment across equity markets. VOO, as a broad-market ETF, was a key beneficiary of this optimism.
Read Also: <a href="https://www.benzinga.com/exclusives/24/10/41405659/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet</a>

Market Vectors ETF Trust Market Vectors Gold Miners

NFLX

TSMC

What's Going On With Vanguard S&P 500 ETF (VOO) This Week?

Wall Street was in positive territory in Friday midday trading, buoyed by upbeat quarterly earnings reports that kept <a href="https://www.benzinga.com/markets">investor sentiment bullish.</a>
Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) surged 10% to fresh record highs after delivering a strong earnings beat. The tech-heavy Nasdaq 100 rose 0.8%, pushing its weekly performance into positive territory for the sixth consecutive week.
The S&amp;P 500 and Dow also edged higher, both on track for the sixth straight week of gains, with the Dow flirting with all-time highs.
Gold miners led industry performance as gold prices hit new record levels above $2,700 per ounce. The VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>) soared over 4%, hitting the highest level in over four years. Friday is poised to mark the fourth straight session of gains for both gold and silver, with silver jumping over 3%, heading for its best day since late September.
West Texas Intermediate (WTI) crude prices tumbled more than 2%, slipping below the $70-per-barrel mark. WTI is down over 8% for the week, on pace for its worst weekly decline since January.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) climbed 2.8% to above $68,800.
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % change</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,352.25</td>
<td>0.8%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,870.75</td>
<td>0.5%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,300.82</td>
<td>0.1%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,279.45</td>
<td>-0.1%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:55 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.5% to $585.12.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.1% higher to $433.01.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.8% to $495.21.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) stalled at $226.03.</li>
<li>The Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) outperformed, up 0.9%. The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 0.6%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
<ul>
<li>Stocks moving in reaction to earnings reports were Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), up over 9%, Crown Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>), up over 4%, Western Alliance Bancorporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>), down 6%, American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>), down 2.4%, Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) down 0.4%, Schlumberger N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) down 3.3%, Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>), down 1.7%, Ally Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>), down 1% and Comerica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>), up 4%. </li>
<li>Lamb Weston Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) soared 10% following a report indicating that activist investor&nbsp;Jana Partners&nbsp;has built a 5% stake in the company.</li>
<li>CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) fell over 6% after the company replaced its CEO and cut its third-quarter outlook.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406623/netflix-should-continue-to-outperform-6-analysts-on-streaming-stocks-q3-earnings">Netflix &#8216;Should Continue To Outperform&#8217;: 6 Analysts On Streaming Stock&#8217;s Q3 Earnings</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Equities

Broad U.S. Equity ETFs

Treasuries

Econ #s

Tech

$BTC

ALLY

SPDR Dow Jones Industrial Average ETF Trust

FITB

Stocks Rise, Netflix Soars To Record Highs, Oil Falls Below $70, Gold Miners Rally: What's Driving Markets Friday?

Evercore ISI Group analyst Vijay Kumar maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a In-Line and raises the price target from $475 to $490.

Price Target

Evercore ISI Group Maintains In-Line on Intuitive Surgical, Raises Price Target to $490

Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) Thursday reported <a href="https://www.benzinga.com/news/24/10/41399062/why-intuitive-surgical-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket">upbeat earnings for its third quarter</a>.
The company reported its results amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
<ul>
<li>RBC Capital Markets <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/606ed90d9e63ea0001ef8211/shagun-singh">analyst Shagun Singh</a> reiterated an Outperform rating, while raising the price target from $525 to $555.</li>
<li>Stifel analyst Rick Wise maintained a Buy rating, while lifting the price target from $475 to $525.</li>
<li>Goldman Sachs <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/66585980a3067c00012c48c0/david-roman">analyst David Roman</a> reaffirmed a Buy rating, while raising the price target from $583 to $604.</li>
<li>Piper Sandler <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6010072ea6fe6f000120d9a0/anthony-elian">analyst Adam Maeder</a> maintained an Overweight rating, while lifting the price target from $495 to $538.</li>
<li>Truist Securities <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/613f4c11b4035700018daeca/brandon-king">analyst Richard Newitter</a> reiterated a Buy rating and price target of $570.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
RBC Capital Markets: Intuitive Surgical reported its third-quarter sales 2% higher than estimates. This was driven by robust procedure volume growth and gross system placements, Singh said in a note. The company also reported a 12% earnings beat on "revenue drop-through and strong margins," he added.
Management raised the low end of their guidance for procedure volumes by 50 basis points (bps) to 16%-17%, with the upper end assuming that bariatric procedures stabilize at the current quarter's rates and that headwinds in Korea and China do not worsen, the analyst stated. Management also lowered their projection for operating expense growth by 50 bps at the midpoint, he added.
Stifel: Intuitive Surgical achieved "one of the fastest installed base growth rates in years, at 15.1%," Wise said. The company is well-positioned to approach 10,000 robots installed by the end of 2024.
The midpoint of the new guidance range implies around 2.6 million procedures in 2024, the analyst stated. "Just seven months following the US da Vinci 5 (dv5) approval, Intuitive is already generating meaningful post-launch growth momentum," which suggests the potential for acceleration in 2025, he further wrote.
Goldman Sachs: Intuitive Surgical reported third-quarter revenues of $2.04 billion. That&#8217;s up 17% year-on-year and ahead of consensus of $2 billion. "Against strong YTD performance, 3Q results underscore sustained momentum in the top-line and, as importantly, the significant earnings leverage and upside in the model," Roman said
The company has "multiple layers of growth," including the continued rollout of dv5 until mid-2025, uptake of the new SP platform and continued adoption of the ION diagnostics system, the analyst stated. "Importantly, with Intuitive's consistent investment in the robotic surgery ecosystem and differentiated technology, we are increasingly confident in the company further extending its competitive advantage," he further wrote.
Piper Sandler: &#8220;We were also encouraged to see another strong placement quarter for DV5 (110 systems in Q3) and hear that ISRG is tracking towards a broad launch in mid-2025," Maeder wrote in a note. Management indicated that physician feedback of the system had been strong, he added.
Leverage was another "bright spot in the quarter," as the company reported adjusted operating margins of 37.0%, well ahead of "our 33.3% bogey," the analyst stated. Although estimates have been raised, there is "ample opportunity for upside to play out going forward," he further wrote.
Truist Securities: Intuitive Surgical delivered a massive beat on DV5, at 110 versus analyst estimate of 78, Newitter said. The upside delivered by DV5 in its soft launch is "particularly encouraging." It gives greater confidence in further estimate upside and growth acceleration into 2025, when the full launch in planned, he added.
Intuitive Surgical should be able to sustain its "already substantial lead" in a large and underpenetrated robotic opportunity.
ISRG Price Action: Shares of Intuitive Surgical had risen by 8.63% to $514.59 at the time of publication on Friday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41404035/autoliv-posts-strong-sales-joins-united-states-cellular-netflix-intuitive-surgical-and-other-big-sto">Autoliv Joins United States Cellular, Netflix, Intuitive Surgical And Other Big Stocks Moving Higher On Friday</a></li>
</ul>
Courtesy of Intuitive Surgical

Earnings Beats

Reiteration

Movers

Intuitive Surgical Posts Q3 Earnings Beat, These Analysts Raise Forecasts On DV5 Uptake

BTIG analyst Ryan Zimmerman maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Buy and raises the price target from $518 to $535.

BTIG Maintains Buy on Intuitive Surgical, Raises Price Target to $535

U.S. stocks were mixed , with the Nasdaq Composite gaining around 100 points on Friday.
Shares of Autoliv, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) rose sharply during Friday's session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/10/41403377/autoliv-surges-despite-mixed-q3-results-chinese-market-mix-drags-performance">third-quarter sales results</a>.
The company reported third-quarter adjusted earnings per share of $1.84, missing the analyst consensus of $1.95. Quarterly revenues of $2.56 billion topped the street view of $2.53 billion.
Autoliv shares jumped 5.5% to $99.13 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) gained 19% to $18.73. Amazon Web Services recently announced plans to invest over $500 million in nuclear power.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) gained 18.7% to $22.25.</li>
<li>Telephone and Data Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) climbed 18% to $29.80.</li>
<li>Peloton Interactive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>) gained 14% to $6.01. Peloton Interactive will release its first quarter fiscal 2025 results before the opening bell on Thursday, Oct. 31.</li>
<li>Uxin Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UXIN#NASDAQ">UXIN</a>) jumped 13.1% to $6.47. Uxin recently announced a strategic partnership with Wuhan City Economic &amp; Technological Development Zone.</li>
<li>United States Cellular Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) gained 13.1% to $66.39. after the company announced the sale of a portion of its retained spectrum licenses to Verizon for $1 billion.</li>
<li>XCHG Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCH#NASDAQ">XCH</a>) gained 12.7% to $22.08.</li>
<li>ClearPoint Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) surged 11.2% to $13.42. ClearPoint Neuro will release financial results for its 2024 third quarter on Thursday, Nov. 7, after the market close.</li>
<li>Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) gained 10.5% to $759.82 following upbeat quarterly results.</li>
<li>IonQ, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NASDAQ">IONQ</a>) surged 8.8% to $13.61. IonQ will report third quarter financial results on Nov. 6.</li>
<li>Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) gained 8.8% to $515.57 following better-than-expected third-quarter financial results.</li>
<li>Nokia Oyj (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) gained 6.3% to $4.6150. Nokia recently company reported worse-than-expected third-quarter EPS and sales.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>

CLPT

IONQ

OKLO

PTON

UXIN

Autoliv Posts Strong Sales, Joins United States Cellular, Netflix, Intuitive Surgical And Other Big Stocks Moving Higher On Friday

Piper Sandler analyst Adam Maeder reiterates Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Overweight and raises the price target from $495 to $538.

Piper Sandler Reiterates Overweight on Intuitive Surgical, Raises Price Target to $538

Stifel analyst Rick Wise maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Buy and raises the price target from $475 to $525.

Stifel Maintains Buy on Intuitive Surgical, Raises Price Target to $525

Wells Fargo analyst Larry Biegelsen maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Overweight and raises the price target from $466 to $549.

Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $549

RBC Capital analyst Shagun Singh maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Outperform and raises the price target from $525 to $555.

RBC Capital Maintains Outperform on Intuitive Surgical, Raises Price Target to $555

Intuitive Surgical: The Price For Its Excellence Is Too High

Erste Group analyst Hans Engel upgraded Intuitive Surgical (ISRG) to Buy from Hold. Published first on TheFly – the ultimate source for real-time, ...

Intuitive Surgical upgraded to Buy from Hold at Erste Group

As previously reported, Erste Group analyst Hans Engel upgraded Intuitive Surgical (ISRG) to Buy from Hold. Sales and profits will increase at doub...

Intuitive Surgical upgraded to Buy at Erste on 'excellent market position'

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

Workday initiated, Kraft Heinz downgraded: Wall Street's top analyst calls

JPMorgan's 'Analyst Focus List' – growth, income, value, short ideas

Intuitive Surgical Is Breaking Ground

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President-...

Trump Trade: President-elect seeks to kill Biden fuel-efficiency rules

BlackRock Unconstrained Equity Fund Q3 2024 Commentary

XLV: Healthcare Stocks In Critical Condition (Rating Downgrade)

Citi Research's U.S. Equity Strategy Large-Cap recommendation list

ABBV

ACRS

ADSK

AGCO

ALRM

AMGN

AMZN

ARMK

ASAN

ASML

ASND

BLNK

BNTX

BRBR

CALX

CDNS

CHPT

CLFD

COST

CVNA

CYBR

DAWN

DELL

DKNG

EWTX

FRSX

GOOGL

GWRE

HBAN

HNDAF

INTU

JNPR

KLAC

KVUE

LEGN

LPLA

LVMHF

MBGAF

MBGYY

MNDY

MRNA

MRVL

NSANF

NSANY

NTRA

OKTA

PODD

RACE

ROIV

RVMD

SCHW

SIRI

SNDX

SPGI

STLA

SWTX

TFII

TRGP

TSLA

TVTX

ULTA

VEEV

VICI

VWAGY

VWAPY

WDAY

WOLF

XENE

Press Releases

Sonder Capital Appoints Kate Garrett as Managing Partner to Lead Next Generation of Growth

Earnings

Intuitive Announces First Quarter Earnings

Management

Intuitive Announces Board of Directors Elections and Retirements

Health Care

Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy

Intuitive Announces Second Quarter Earnings

Intuitive President David J. Rosa Appointed to Intuitive Board of Directors

Neptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular

Jupiter Endovascular Exits Stealth With $21M in New Financing to Fund Pivotal Trial for Pulmonary Embolism

Comments

Intuitive Surgical

Vendite allo scoperto

Intuitive Surgical (NASDAQ:ISRG) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO